|
Clinical Services
Prostate Diseases
Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is commonly known as an enlarged prostate. The prostate is a
walnut-sized gland located beneath the bladder and in front of the rectum and is surrounded by
fibrous tissue. Sometimes this tissue growth interferes with urination. According to the National
Institutes of Health, BPH affects 50% of the men age 60 or older and 90% of men over the age of 70.
Common symptoms of benign prostatic hyperplasia include the following:
Blood in the urine (i.e. hematuria) cased by straining to void
- Dribbling after voiding
- Feeling that the bladder has not emptied completely after urination
- Frequent urination, particularly at night (i.e. nocturia)
- Hesitant, interrupted, or weak urine stream caused by decreased force
- Leakage of urine (i.e. overflow incontinence)
- Pushing or straining to begin urination
- Recurrent, sudden, urgent need to urinate
The GreenLight Laser System
The GreenLight Laser
System is a new innovative treatment for BPH which involves Photoselective Vaporization of the Prostate
(PVP). This is a state-of-the-art definitive treatment solution that delivers the objective outcomes of a
transurethral resection of the prostate (TURP) with the lowest rate of adverse events of any interventional
BPH treatment.
Dramatic urine flow improvement, rapid symptom relief, minimal side-effects, preservation of sexual function
and long lasting durability are the hallmarks of this breakthrough treatment and the reason Photoselective
Vaporization of the Prostate using the GreenLight Laser System is quickly becoming the new standard of care
for BPH.
|
